Back

Discussion – Would cost matter in laboratory test-based risk assessment?

14 April 2023 (13:55 - 14:00)
Organised by:
Congress Presentation Part of: Biomarkers for cardiovascular risk assessment: practical issues Biomarkers Open Access ESC Preventive Cardiology 2023

5 More presentations in this session

Presentation thumbnail
Laboratory based risk assessment vs. clinical tools in risk prediction
Professor W. Maerz (Mannheim, DE)
Slides Video
Presentation thumbnail
Discussion – Laboratory based risk assessment vs. clinical tools in risk prediction
Presentation thumbnail
Laboratory test example: CoroPrevention score
Doctor R. Laaksonen (Tampere, FI)
Slides Video
Presentation thumbnail
Discussion – Laboratory test example: CoroPrevention score
Presentation thumbnail
Would cost matter in laboratory test-based risk assessment?
Mr D. Pollard (Sheffield, GB)
Slides Video

Access the full session

Session thumbnail
Biomarkers for cardiovascular risk assessment: practical issues
Video

The Event

Event poster

ESC Preventive Cardiology 2023

14 April 2023 13:55 CET
You may be interested in
thumbnail
Congress Presentation
Lp(a) as independent causal risk factor: why should we focus on testing?
28 August 2022
thumbnail
Congress Presentation
Risk results from screening for a high cardiovascular disease risk by means of traditional risk factor measurement or coronary artery calcium scoring in the ROBINSCA trial
28 August 2020
thumbnail
Webinar
ACVC Biomarker Talk Series - How to implement novel diagnostic algorithms in the emergency room
19 January 2022
thumbnail
ESC Journals
Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost–effectiveness and cost–utility analyses
24 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources